Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference Morgan Stanley Global Healthcare Conference 2013 Business Wire CAMBRIDGE, Mass. -- September 3, 2013 Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2013 at 4:05 p.m. Eastern Time at the Grand Hyatt New York. A live webcast of Ironwood’s presentation will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood’s website for 14 days following the conference. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (NASDAQ: IRWD) is committed to the art and science of making medicines, from discovery through commercialization. We’re focused on three goals: transforming knowledge into medicines that make a difference for patients, creating value that will inspire the continued support of our fellow shareholders, and building a team that passionately pursues excellence. Our first product, linaclotide, is approved in the United States and Europe. Our pipeline priorities include exploring further opportunities for linaclotide, leveraging our deep expertise in functional gastrointestinal disorders, and advancing programs in other areas such as allergic conditions, cardiovascular disease, central nervous system disorders and other conditions defined by patient symptoms.Ironwood was founded in 1998 and is headquartered in Cambridge, Mass. Connect with us at www.ironwoodpharma.com or on Twitter at www.twitter.com/ironwoodpharma to learn more about Ironwood. Information that may be important to investors will be routinely posted in both these locations. Contact: Ironwood Pharmaceuticals, Inc. Media Relations Lisa Buffington, 617-374-5103 Vice President, Corporate Communications email@example.com or Investor Relations Meredith Kaya, 617-374-5082 Director, Investor Relations firstname.lastname@example.org
Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.